Mitchell Urges Congress To Pass Bipartisan Solutions To Address Anticompetitive Behavior And To Allow Medicare To Negotiate Lower Drug Prices

"We stand with the Alzheimer’s Association in its denunciation of the price set by Biogen for the drug Aduhelm."

“Today, we are watching our drug pricing system break under the weight of Medicare’s inability to negotiate lower drug prices."